Trade COYA anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
Coya Therapeutics, Inc. (COYA) is trading at US$4.76, up 4.62% today as of Sep 4, 16:00 EDT. The company has a market capitalisation of US$114.24M. Over the past 52 weeks, COYA has traded between US$3.71 and US$7.75. On Syfe you can trade COYA with $0 commission and add it to your watchlist.
| Previous close | US$4.55 |
|---|---|
| Market cap | US$114.24M |
| 52-week range | US$3.71 – US$7.75 |
| Volume | 75.63K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Coya Therapeutics, Inc.
Coya Therapeutics, Inc. is a clinical-stage biotechnology company which engages in developing proprietary medicinal products to modulate the function of regulatory T cells. The company was founded by Howard Berman in 2020 and is headquartered in Houston, TX.
Year: 2022
Coya Therapeutics Says Phase 2 ALS Study Enters Blinded Extension Phase
Jun 8, 1:22 PM · MT Newswires
Roth Capital Initiates Coverage on Coya Therapeutics With Buy Rating, $12 Price Target
Jun 5, 11:28 AM · MT Newswires
Coya Therapeutics, Inc. (COYA) stock is trading at US$4.76, +4.62% from the previous close of US$4.55.
The market cap for Coya Therapeutics, Inc. (COYA) stock is approximately US$114.24M.
The 52-week high for Coya Therapeutics, Inc. (COYA) stock is US$7.75.
The 52-week low for Coya Therapeutics, Inc. (COYA) stock is US$3.71.
Coya Therapeutics, Inc. (COYA) does not currently pay a dividend.
Stay on top of COYA
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
